Company intelligence / Profile preview

US Oncology Research

The Woodlands, Texas, United States

Ownership: Private
Development stage: Other

Overview

US Oncology Research is a leading US-based clinical research organization conducting over 400 active oncology clinical trials at a time, contributing to more than 100 FDA-approved cancer therapies and enrolling over 80,000 patients since 1999. The organization's network facilitates trial access in local communities and has played a role in drug development across all major regulatory stages.[1][2][4]

Therapeutic areas: Oncology
Modalities: Small moleculeMonoclonal antibodyAntibody-drug conjugateCell therapyRadiopharmaceuticalBiologic
Industry: Contract Research Organization

Partnerships

Sarah Cannon Research Institute (joint venture with HCA Healthcare and McKesson)Numerous pharmaceutical and biotech sponsors (unspecified due to breadth of activity)[2][4]

Beyond the preview

Go deeper on US Oncology Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on US Oncology Research.

Explore the full profile